Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Natalia Cristina Drosu, M.D., Ph.D.

Concepts (57)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Natalia Drosu's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Natalia Drosu has written about over time.
Lamivudine, 1 publications between 2018 and 2018, average publication date February 2018. Multiple Sclerosis, Relapsing-Remitting, 1 publications between 2018 and 2018, average publication date February 2018. Reverse Transcriptase Inhibitors, 1 publications between 2018 and 2018, average publication date February 2018. Zidovudine, 1 publications between 2018 and 2018, average publication date February 2018. DNA Replication, 1 publications between 2020 and 2020, average publication date May 2020. Nucleic Acid Synthesis Inhibitors, 1 publications between 2020 and 2020, average publication date May 2020. Viral Proteins, 1 publications between 2020 and 2020, average publication date May 2020. Epstein-Barr Virus Infections, 7 publications between 2018 and 2024, average publication date April 2022. Antiviral Agents, 3 publications between 2020 and 2024, average publication date April 2022. Epstein-Barr Virus Nuclear Antigens, 2 publications between 2021 and 2024, average publication date September 2022. Herpesvirus 4, Human, 6 publications between 2020 and 2024, average publication date December 2022. Multiple Sclerosis, 6 publications between 2021 and 2024, average publication date August 2023. HIV Infections, 2 publications between 2024 and 2024, average publication date January 2024. Celiac Disease, 1 publications between 2024 and 2024, average publication date October 2024. B-Lymphocytes, 2 publications between 2024 and 2024, average publication date October 2024. Antigen Presentation, 1 publications between 2024 and 2024, average publication date October 2024. CD4-Positive T-Lymphocytes, 1 publications between 2024 and 2024, average publication date October 2024. Epitopes, T-Lymphocyte, 1 publications between 2024 and 2024, average publication date October 2024.

To see the data from this visualization as text, click here.
Drosu's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (57)
Explore
_
Co-Authors (8)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.